A new report released by Persistence Market Research, estimates the North America scar treatment market’s value at $3,240.3 million in 2015 and $4,190.6 million by 2022, with a CAGR of 3.8% over the forecast period.

A media release from Persistence Market Research explains that North America is expected to be the dominant region in the North American market, and revenue is estimated to increase from $2,845.2 million in 2015 to $3,691.5 million by 2022 with a CAGR of 3.8%.

The scar treatment market is divided into the following segments: topical treatment, laser treatment, surface treatment, and injections. Of these, the topical treatment segment is expected to dominate by 2022 owing to ease of use, low price, and lesser side effects associated with the treatment, per the release.

Product type is segmented into topical products, laser treatment products, surface treatment, and injectable. The topical product segment is estimated to register an above average growth rate over the forecast period, but the laser treatment product segment is projected to register the highest CAGR—5%.

Regarding distribution channels, the scar treatment market is divided into hospitals, clinics, pharmacies and drug stores, and e-Commerce. The hospital segment is estimated to account for 37.8% of the North America market value by 2016 and further increase to 38.6% by 2022, according to the release.

For more information, visit Persistence Market Research.

[Source(s): Persistence Market Research, PR Newswire]